ARCHIVES

Taxol Plus Carboplatin Increased Survival Of NSCLC In Patients 70 And Older

This article is from The Cancer Letter archive.

Vol. 33 No. 6 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

August 31, 2012

Lasker Awards Announced

September 25, 2009

NCCS Begins Program To Help Develop Survivors’ Care Plan

February 27, 2009

Particle Therapy Program Would cost $600 million Over 10 Years for 16 Facilities, Clinical Trials

December 2, 1977

In Brief: CTRC Opens New Building With Ceremony For Survivors; WistarWins NASA Grant

June 9, 1995

Continuing Resolution Funds Agencies Through Dec. 5.

November 17, 2000